Product NDC: | 63323-393 |
Proprietary Name: | Colistimethate |
Non Proprietary Name: | COLISTIMETHATE SODIUM |
Active Ingredient(s): | 150 mg/2mL & nbsp; COLISTIMETHATE SODIUM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-393 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065364 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091204 |
Package NDC: | 63323-393-06 |
Package Description: | 1 VIAL in 1 BOX (63323-393-06) > 2 mL in 1 VIAL |
NDC Code | 63323-393-06 |
Proprietary Name | Colistimethate |
Package Description | 1 VIAL in 1 BOX (63323-393-06) > 2 mL in 1 VIAL |
Product NDC | 63323-393 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | COLISTIMETHATE SODIUM |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20091204 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | COLISTIMETHATE SODIUM |
Strength Number | 150 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |